Arcutis Biotherapeutics Inc (ARQT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
9.12
-0.08
(-0.87%)
After-Hours: 20:00
Arcutis Biotherapeutics Debt to Equity Ratio: 0.9016 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.9016 |
December 31, 2023 | 2.276 |
September 30, 2023 | 4.298 |
June 30, 2023 | 2.481 |
Date | Value |
---|---|
March 31, 2023 | 1.422 |
December 31, 2022 | 0.9436 |
September 30, 2022 | 0.7266 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7266
Minimum
Sep 2022
4.298
Maximum
Sep 2023
1.864
Average
1.422
Median
Mar 2023
Debt to Equity Ratio Benchmarks
AdaptHealth Corp | 1.504 |
Prestige Consumer Healthcare Inc | 0.6802 |
Pfizer Inc | 0.7445 |
Adverum Biotechnologies Inc | -- |
Karuna Therapeutics Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 478.54M |
Total Liabilities (Quarterly) | 253.60M |
Shareholders Equity (Quarterly) | 224.94M |
Current Ratio | 9.894 |
Net Debt Paydown Yield | -0.09% |